Early benefit with empagliflozin in heart failure with preserved ejection fraction: insights from the EMPEROR‐Preserved trial
Fichier principal
European J of Heart Fail - 2022 - Butler - Early benefit with empagliflozin in heart failure with preserved ejection.pdf (1)
Télécharger le fichier
Origin | Publisher files allowed on an open archive |
---|